Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors

Author:

Zhai Yinghong¹,Hu Fangyuan²³,Shi Wentao¹³,Ye Xiaofei³,Xu Jingfang³,Guo Xiaojing³,Cao Yang⁴^ORCID,He Jia³,Xu Feng¹

Affiliation:

1. Clinical Research Center, School of Medicine, Shanghai Ninth People’s Hospital Affiliated to Shanghai JiaoTong University, Shanghai, China

2. Department of Medical Service, Naval Hospital of Eastern theater, Zhejiang, Zhoushan, China

3. Department of Health Statistics, Second Military Medical University, Shanghai, China

4. Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden

Funder

the National Nature Science Foundation of China

the Leading Talents of Public Health in Shanghai

the Shanghai Municipal Commission of Health and Family Planning Fund for Excellent Young Scholars

the Excellent Young Scholars of Public Health in Shanghai

three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System

ig Data and Artificial Intelligence Application, Military Key Discipline Construction Project

Medical and Health Project of Zhoushan Municipal Health Commission

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

Reference48 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献